Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,653Revenue $M97.6Net Margin (%)-30.4Altman Z-Score97.3
Enterprise Value $M5,345EPS $-0.2Operating Margin %-19.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.2Pre-tax Margin (%)-30.4Higher ROA y-yY
Price/Book18.010-y EBITDA Growth Rate %--Quick Ratio11.2Cash flow > EarningsY
Price/Sales55.75-y EBITDA Growth Rate %--Current Ratio11.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-1,300.0ROA % (ttm)-10.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-15.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M147ROIC % (ttm)-582.7Gross Margin Increase y-yN

Gurus Latest Trades with DYAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DYAXMario Gabelli 2015-12-31 Buy 0.05%$19.78 - $37.74
($32.46)
$ 38.4118%New holding187,150
DYAXKen Fisher 2015-09-30 Add$17.68 - $28.34
($23.88)
$ 38.4161%Add 1.60%185,375
DYAXKen Fisher 2015-03-31 Buy 0.01%$13.55 - $17.54
($15.57)
$ 38.41147%New holding182,450
DYAXJoel Greenblatt 2015-03-31 Sold Out -0.006%$13.55 - $17.54
($15.57)
$ 38.41147%Sold Out0
DYAXJoel Greenblatt 2014-06-30 Buy 0.01%$6.11 - $9.96
($7.59)
$ 38.41406%New holding46,505
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DYAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DYAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KEMPNER THOMAS LDirector 2015-09-10Sell6,000$22.4770.94view
KEMPNER THOMAS LDirector 2015-08-28Sell17,947$23.8361.18view
KEMPNER THOMAS LDirector 2015-08-18Sell18,035$23.8361.18view
MIGAUSKY GEORGE VEVP & CFO 2015-08-17Sell125,000$22.8568.1view
KEMPNER THOMAS LDirector 2015-08-13Sell4,848$23.8161.32view
KEMPNER THOMAS LDirector 2015-08-11Sell120,800$23.8161.32view
Christensen GustavCEO and President 2015-08-05Sell250,000$23.8660.98view
Bazemore ToddEVP & Chief Commercial Officer 2015-08-05Sell43,000$23.6262.62view
KEMPNER THOMAS LDirector 2015-08-04Sell7,000$24.2458.46view
Ashe Andrew D.General Counsel & EVP 2015-08-03Sell62,320$24.2158.65view

Quarterly/Annual Reports about DYAX:

News about DYAX:

Articles On GuruFocus.com
Mario Gabelli Comments on Dyax Corp Jan 29 2016 
Chuck Royce Makes Big Gains on Divestitures Jan 03 2016 
Voltari Corp. (VLTC) Under Carl Icahn Umbrella, Dyax Corp. (DYAX) Potential Angioedema Preventive Tr Apr 01 2015 
Weekly CFO Buys Highlight: DYAX, IBI, FARM, TAP, DBM Mar 19 2011 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 10,000 Shares Mar 15 2011 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 10,000 Shares Mar 15 2011 
Dyax Corp. Reports Operating Results (10-K) Mar 02 2011 
Dyax Corp. Reports Operating Results (10-Q) Nov 02 2010 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 5,000 Shares Sep 15 2010 
Dyax Corp. (DYAX) CFO George V Migausky buys 12,000 Shares Aug 25 2010 

More From Other Websites
Shire sets out bullish guidance for 2016 after beating quarterly forecasts Feb 11 2016
Here Are The Most Notable Insider Transactions Hitting The Market Jan 26 2016
Shire stays mum on Burlington facilities, employees in wake of Dyax acquisition Jan 25 2016
DYAX CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of... Jan 22 2016
Shire Completes Acquisition of Dyax Jan 22 2016
Shire Completes Acquisition of Dyax Jan 22 2016
Technical Scrutiny on Biotechnology Stocks -- Gilead Sciences, Sarepta Therapeutics, Dyax Corp., and... Jan 21 2016
3 Stocks Making New 52-Week Highs Jan 20 2016
[$$] The Judge Who Shoots Down Merger Lawsuits Jan 11 2016
[$$] The Judge Who Shoots Down Merger Lawsuits Jan 10 2016
The Zacks Analyst Blog Highlights: ALPS Medical Breakthroughs ETF, Anacor Pharmaceuticals, Dyax,... Dec 29 2015
5 Top Performing Stocks of the Top ETF of 2015 Dec 28 2015
Here are the 20 top-performing stocks in Mass. for 2015 Dec 14 2015
DYAX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 11 2015
Dyax Corp. Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed... Dec 11 2015
Dyax Corp. Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed... Dec 11 2015
DYAX CORP Financials Dec 08 2015
Dyax Corp. Presents Phase 1b DX-2930 Data at the American College of Allergy, Asthma, and Immunology... Dec 08 2015
Dyax Corp. Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting Dec 08 2015
Dyax Corp. Announces Early Termination of Hart-Scott-Rodino Waiting Period Dec 08 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK